Add Company
Join Now

NBE-Therapeutics AG Revenue and Competitors

License our Company Data API

Basel,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • NBE-Therapeutics AG's estimated annual revenue is currently $7.1M per year.(i)
  • NBE-Therapeutics AG's estimated revenue per employee is $155,000

Employee Data

  • NBE-Therapeutics AG has 46 Employees.(i)
  • NBE-Therapeutics AG grew their employee count by 5% last year.

NBE-Therapeutics AG's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is NBE-Therapeutics AG?

At NBE Therapeutics we strive to develop best-in-class oncology treatments to increase survival and improve quality of life for cancer patients worldwide. Through our highly innovative novel in-house developed technologies, we have created a next generation antibody drug conjugate platform targeting solid tumors. Our platform allows us to develop targeted medicines, that through a long-lasting immune oncology effect, could reduce or even eradicate tumors. Our dedicated international team has been able to create a pipeline of ADC product candidates in various stages of development to enter clinical phases to create better treatments for cancer patients in need of more selective drugs.

keywords:N/A

N/A

Total Funding

46

Number of Employees

$7.1M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.9M4615%N/A
#2
$9.8M4820%N/A
#3
$5.5M49-4%N/A
#4
N/A5019%N/A
#5
$7.2M5028%N/A